Improving Access to Cell and Gene Therapy in Pediatrics
October 2, 2024
Gene therapy holds tremendous potential for children, but many promising therapies are shelved. Here’s what a new model could look like.
Alan S. Wayne, MD News
What Is Gene Therapy?
August 26, 2024
How next-generation gene therapies target the underlying causes of genetic diseases.
Children’s Hospital Los Angeles Neurologist Honored With Prestigious Research Award
March 4, 2024
Children’s Hospital Los Angeles neurologist Shafali Spurling Jeste, MD, received the 2024 Martha Bridge Denckla Award from the Child Neurology Society.
Children’s Hospital Los Angeles Awarded $6 Million from CIRM to Advance CAR T-Cell Therapies in Recurring Solid Tumors in Children
February 29, 2024
CHLA Researchers receive CIRM award to develop regenerative therapy for recurring solid tumors in children.
Children’s Hospital Los Angeles Names Alan S. Wayne, MD, as Pediatrician-in-Chief and Senior Vice President of Academic Affairs
September 14, 2023
Wayne also named as Chair of the Department of Pediatrics at Keck School of Medicine of USC.
Children’s Hospital Los Angeles Offers MIBG Therapy for Neuroblastoma
July 15, 2022
Children with high-risk neuroblastoma can now access MIBG therapy in Southern California, at Children’s Hospital Los Angeles.
A Partnership Is Making a 'Huge Impact' on Childhood Cancer
May 16, 2021
5 Questions for Jeri Wilson, Executive Director of the Pediatric Cancer Research Foundation
New cGMP Facility to Benefit Patient Care and Research
April 20, 2021
A state-of-the-art cell therapeutics facility will support the translation of novel cell therapy and tissue engineering approaches into clinical testing for a wide range of human diseases.
Diet + Exercise + Chemo = Increased Survival in Youth with Leukemia
April 1, 2021
Children’s Hospital Los Angeles study finds risk of detectable cancer cells decreased by 70% after one month of treatment in patients with ALL.
Diet + Exercise + Chemo = Increased Survival in Youth with Leukemia
April 1, 2021
Risk of detecting cancer cells decreased by 70% after one month of treatment